271 related articles for article (PubMed ID: 25128526)
1. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
2. Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease.
Yu G; Yan T; Feng Y; Liu X; Xia Y; Luo H; Wang JZ; Wang X
Neurobiol Aging; 2013 Jul; 34(7):1748-58. PubMed ID: 23374587
[TBL] [Abstract][Full Text] [Related]
3. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
Arnaud L; Chen S; Liu F; Li B; Khatoon S; Grundke-Iqbal I; Iqbal K
FEBS Lett; 2011 Sep; 585(17):2653-9. PubMed ID: 21806989
[TBL] [Abstract][Full Text] [Related]
5. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
[TBL] [Abstract][Full Text] [Related]
6. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer disease and amyotrophic lateral sclerosis: an etiopathogenic connection.
Wang X; Blanchard J; Grundke-Iqbal I; Wegiel J; Deng HX; Siddique T; Iqbal K
Acta Neuropathol; 2014 Feb; 127(2):243-56. PubMed ID: 24136402
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.
Chasseigneaux S; Clamagirand C; Huguet L; Gorisse-Hussonnois L; Rose C; Allinquant B
BMC Neurosci; 2014 Jun; 15():82. PubMed ID: 24981783
[TBL] [Abstract][Full Text] [Related]
9. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation.
Wang Y; Yang R; Gu J; Yin X; Jin N; Xie S; Wang Y; Chang H; Qian W; Shi J; Iqbal K; Gong CX; Cheng C; Liu F
Neurobiol Aging; 2015 Jan; 36(1):188-200. PubMed ID: 25219467
[TBL] [Abstract][Full Text] [Related]
11. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
12. Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.
Chohan MO; Khatoon S; Iqbal IG; Iqbal K
FEBS Lett; 2006 Jul; 580(16):3973-9. PubMed ID: 16806196
[TBL] [Abstract][Full Text] [Related]
13. SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments.
Qin M; Li H; Bao J; Xia Y; Ke D; Wang Q; Liu R; Wang JZ; Zhang B; Shu X; Wang X
Acta Neuropathol Commun; 2019 Feb; 7(1):21. PubMed ID: 30767764
[TBL] [Abstract][Full Text] [Related]
14. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
15. GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.
Chu D; Tan J; Xie S; Jin N; Yin X; Gong CX; Iqbal K; Liu F
J Alzheimers Dis; 2016; 49(2):365-75. PubMed ID: 26484916
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic strategies for neurodegenerative disease.
Tanimukai H; Kudo T; Tanaka T; Grundke-Iqbal I; Iqbal K; Takeda M
Psychogeriatrics; 2009 Jun; 9(2):103-9. PubMed ID: 19604333
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
[TBL] [Abstract][Full Text] [Related]
19. Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice.
Liu GP; Wei W; Zhou X; Shi HR; Liu XH; Chai GS; Yao XQ; Zhang JY; Peng CX; Hu J; Li XC; Wang Q; Wang JZ
Mol Ther; 2013 Dec; 21(12):2247-57. PubMed ID: 23922015
[TBL] [Abstract][Full Text] [Related]
20. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
